SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 70 filers reported holding SPERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 11.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301,375 | -16.6% | 249,070 | 0.0% | 0.68% | +10.1% |
| Q2 2023 | $361,152 | 0.0% | 249,070 | 0.0% | 0.62% | -14.6% |
| Q1 2023 | $361,152 | -16.2% | 249,070 | 0.0% | 0.72% | +2.6% |
| Q4 2022 | $430,891 | -13.5% | 249,070 | 0.0% | 0.70% | -9.3% |
| Q3 2022 | $498,000 | +169.2% | 249,070 | 0.0% | 0.78% | +203.9% |
| Q2 2022 | $185,000 | -91.5% | 249,070 | 0.0% | 0.26% | -84.5% |
| Q1 2022 | $2,167,000 | -45.7% | 249,070 | 0.0% | 1.65% | -8.2% |
| Q4 2021 | $3,988,000 | – | 249,070 | – | 1.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 3,932,209 | $76,246,000 | 15.85% |
| Atlas Venture Associates XI, LLC | 1,376,968 | $26,700,000 | 4.23% |
| Atlas Venture Associates IX, LLC | 1,376,968 | $26,700,000 | 4.23% |
| BVF INC/IL | 2,243,278 | $43,497,000 | 1.71% |
| AWM Investment Company, Inc. | 372,755 | $7,228,000 | 0.92% |
| Alphabet Inc. | 889,979 | $17,257,000 | 0.83% |
| Rock Springs Capital Management LP | 1,235,000 | $23,947,000 | 0.51% |
| Novo Holdings A/S | 576,702 | $11,182,000 | 0.48% |
| Artal Group S.A. | 500,000 | $9,695,000 | 0.21% |
| Granahan Investment Management | 420,320 | $8,150,000 | 0.18% |